Atlas Trials

GC/GEJC

6 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch GC/GEJC

RecordFirmDate
Sacituzumab Tirumotecan (Sac-TMT/SKB264) Plus Tagitanlimab (KL-A167) in Patients With Recurrent or Metastatic Esophageal Squamous Cell Carcinoma and Gastric/Gastroesophageal Junction Adenocarcinoma (NCT07701681)Sun Yat-sen University2026-08-31
Phase Ib/IIa Open-label Study, to Evaluate Safety, Tolerability, and Antitumor Activity of HCB101 in Combination With Multiple Agents in Subjects With Advanced Gastric or Gastro-esophageal (GEJ) Adenocarcinoma (NCT07680569)Kaohsiung Medical University Chung-Ho Memorial Hospital2026-06-01
Disitamab Vedotin Combined With SOX Regimen Versus SOX Alone as Adjuvant Therapy for HER2-Moderate/High Expressing Stage Ⅲ Gastric Cancer: A Prospective, Multicenter, Randomized, Phase Ⅱ Clinical Trial (NCT07474324)The First Affiliated Hospital with Nanjing Medical University2026-03-15
A Random, Non-controlled, Open Clinical Study of Apatinib Mesylate Combined With Albumin-bound Paclitaxel ± Adebrelimab in Treating Advanced Second-line Gastric Cancer (NCT07770113)The First Affiliated Hospital of Zhengzhou University2025-06-30
Mecapegfilgrastim Combined With Adebrelimab and Chemotherapy as Neoadjuvant Therapy in Resectable GC/GEJC (NCT06684158)The First Affiliated Hospital with Nanjing Medical University2024-11-30
A Phase II Trial of Perioperative Adebrelimab Combined With XELOX in Resectable Locally Advanced Gastric/Gastroesophageal Junction Cancer (GC/GEJC) (NCT06506292)Tianjin Medical University Cancer Institute and Hospital2024-07-01

Track GC/GEJC automatically

Every clearance here is in the API, with alerts when new ones post.